Search All News
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Innovation and discovery are at the heart of Herbert Irving Comprehensive Cancer Center's mission to reduce the burden of cancer. Learn more in the HICCC's 2021 annual report.
- September 30, 2021
Despite clinical guidelines that advocate surgery as a first step, a Columbia study suggests many patients with advanced ovarian cancer should be treated with chemotherapy before surgery.
- September 29, 2021
Just 17 when diagnosed with advanced cervical cancer, Sheneque Hanse is now in remission after two years of treatment and eager to start a career in health care to help others with cancer.
- September 9, 2021
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.
- September 3, 2021
Yoon, a surgical oncologist expert in the treatment of gastric cancer, sarcoma, and melanoma, is also the new vice chair of surgical oncology research and education in the Department of Surgery.
- July 26, 2021
A new robotic device from researchers at VP&S and Columbia Engineering could help guide recovery after treatment for head and neck cancer.
- July 9, 2021
A new brain cancer study is testing an ultrasound technology developed at Columbia to determine if the technology can open the blood-brain barrier and improve delivery of chemotherapy.
- July 1, 2021
Even a brief exposure to addictive medications for surgery-related pain or anxiety can lead to long-term use, a study by Columbia researchers has found.
- June 22, 2021
New guidelines encourage initial screening for colorectal cancer at 45 instead of 50, because younger people are increasingly being diagnosed with the disease, says Columbia's James Church, MD.